Peregrine Pharmaceuticals reported $6.46M in Trade Creditors for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US $ 34.54M 4.06M
Amgen AMGN:US $ 1403M 37M
Biocryst Pharmaceuticals BCRX:US $ 13.88M 13.93M
Bristol Myers Squibb BMY:US $ 2944M 5M
Celldex Therapeutics CLDX:US $ 1.02M 0.21M
Chemocentryx CCXI:US $ 5.42M 1.32M
Eli Lilly And LLY:US $ 1433.3M 237.3M
Immunogen IMGN:US $ 16.06M 2.37M
Intrexon XON:US $ 4.42M 0.99M
Karyopharm Therapeutics KPTI:US $ 3.44M 1.84M
Macrogenics MGNX:US $ 3.73M 11.77M
Mannkind MNKD:US $ 8.7M 1.75M
Merk MRK:US $ 3715M 894M
Minerva Neurosciences NERV:US $ 1.59M 0.27M
Newlink Genetics NLNK:US 1.8M 1.19M
Novartis NOVN:VX 5.08B 470M
Novavax NVAX:US $ 135.13M 8.08M
Peregrine Pharmaceuticals PPHM:US $ 6.46M 3.55M
Repligen RGEN:US $ 38.28M 2.08M
Xencor XNCR:US $ 11.9M 2.1M